Massive dilutive offering at a deep discount signals significant capital needs and likely crushes near-term equity value. Watch for the stock to reprice below the offering price post-close; any secondary or insider participation at this level does not change the arithmetic of 2/3 dilution. The EIB draw adds further debt overhang. Avoid the equity until the offering settles and price discovery resumes.
Price Chart
Executive Summary
Nyxoah priced a $95M underwritten public offering of ~55.2M shares at $1.72/share, a ~24% discount to the prior close implied by the $126M pre-deal market cap. The massive dilution (~67% of shares outstanding) signals acute cash needs; the company also plans to draw €13.8M from its EIB loan in Q2 2026. Proceeds are earmarked for US commercialization, R&D, and general corporate purposes.
Key Financial Metrics
Key Facts
- Priced 55,232,558 ordinary shares at $1.72/share for ~$95M gross proceeds
- Underwriters have a 30-day option to purchase up to 8,284,883 additional shares
- Offering is being made under an effective shelf registration on Form F-3 (File No. 333-285982)
- Expected to close on or around June 9, 2026
- Nyxoah intends to draw €13.8M from the second tranche of its EIB loan in Q2 2026
- Chairman Robert Taub and independent directors Jürgen Hambrecht and Kevin Rakin expressed interest in participating in the offering
- A committee of independent directors assessed the related-party participation and concluded the transaction is on market terms
Financial Impact
$95M gross proceeds; ~67% dilution on a base of ~82.5M shares pre-offering (approximately 66.8M shares outstanding per the company's last 20-F plus the 55.2M new shares); offering price of $1.72/share
Risk Factors
- Extreme dilution — the offering adds ~67% to the share count, severely depressing per-share metrics
- Potential overhang from the underwriters' option (additional 8.3M shares) and the planned EIB draw of €13.8M
- Commercialization of the Genio system in the US may not generate sufficient revenue to justify the capital raise
- The stock may trade below the $1.72 offering price as the market absorbs the new supply
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3307491 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 6-K | $0.8950 $0.8220 | ▲ +8.16% | ▲ +6.98% | $0.9006 (−0.63%) |
Oct 19, 2026 8d ago | Press Release | $0.9540 $0.9400 | ▲ +1.47% | ▲ +1.80% | $0.9006 (+5.60%) |
Sep 22, 2026 4w ago | 6-K | $1.33 $1.27 | ▼ −4.51% | ▼ −4.43% | $0.9006 (−32.29%) |
Jun 23, 2026 17w ago | 6-K | $1.62 $1.63 | ▼ −0.62% | ▼ −0.47% | $0.9006 (+44.41%) |
Jun 11, 2026 19w ago | 6-K | $1.39 $1.55 | ▼ −11.51% | ▼ −9.75% | $0.9006 (+35.21%) |
Jun 8, 2026 20w ago | 6-K | $1.34 $1.31 | ▲ +2.24% | ▲ +0.66% | $0.9006 (+32.79%) |
Jun 8, 2026 20w ago | 424B5 | $1.39 $1.34 | ▲ +3.60% | ▲ +3.30% | $0.9006 (+35.21%) |
Jun 5, 2026 20w ago | Press Release | $1.45 $1.39 | ▲ +4.14% | ▲ +4.36% | $0.9006 (+37.89%) |
Jun 4, 2026 20w ago | 424B5 | $1.45 $1.39 | ▲ +4.14% | ▲ +4.36% | $0.9006 (+37.89%) |
May 20, 2026 22w ago | Press Release | $2.87 $2.87 | · 0.00% | ▼ −0.45% | $0.9006 (−68.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers